Inventor · disambiguated record
Shujaath Mehdi
Also filed as: MEHDI SHUJAATH
20 granted patents·3 pending applications·243 citations·filing 1993–2012
94Inventor score
Files withMERRELL PHARMA INC10AVENTIS PHARMA INC3HOECHST MARION ROUSSEL INC3MERRELL DOW PHARMA2WEINTRAUB PHILIP M2
Top patents by PatentIndex Score
23 records- 0186US8008491B2Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)AVENTIS PHARMA INC·Filed 2008·Granted Aug 30, 2011·15 cites·2 claims
- 0280US5736520APeptidase inhibitorsMERRELL PHARMA INC·Filed 1995·Granted Apr 7, 1998·55 cites·1 claims
- 0376US5691368ASubstituted oxazolidine calpain and/or cathepsin B inhibitorsHOECHST MARION ROUSSEL INC·Filed 1995·Granted Nov 25, 1997·41 cites·16 claims
- 0472US7405300B2Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)AVENTIS PHARMAVEUTICALS INC·Filed 2004·Granted Jul 29, 2008·13 cites·9 claims
- 0571US5510333AInhibitors of Cathepsin G and elastase for preventing connective tissue degradationMERRELL PHARMA INC·Filed 1995·Granted Apr 23, 1996·29 cites·10 claims
- 0668US5430145AMercaptoacetylamide derivatives useful as inhibitors of enkephalinase and aceMERRELL DOW PHARMA·Filed 1993·Granted Jul 4, 1995·34 cites·27 claims
- 0765US5948886AAcylated enol derivatives of α-ketoesters and α-ketoamidesHOECHST MARION ROUSSEL INC·Filed 1997·Granted Sep 7, 1999·28 cites·12 claims
- 0863US8173682B2Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)WEINTRAUB PHILIP M·Filed 2006·Granted May 8, 2012·1 cites·6 claims
- 0954US5661167AProlyl endopeptidase inhibitorsMERRELL PHARMA INC·Filed 1996·Granted Aug 26, 1997·10 cites·6 claims
- 1053US5491143AMercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACEMERRELL DOW PHARMA·Filed 1995·Granted Feb 13, 1996·4 cites·2 claims
- 1147US5731306AMercaptoacetylamido 1,3,4,5-tetrahydro-benzo c!azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and aceFiled 1996·Granted Mar 24, 1998·6 cites·18 claims
- 1240US2010143937A1ASSAY METHODS FOR IDENTIFYING AGENTS THAT MODIFY THE ACTIVITY OF NAPE-PLD OR Abh4SANOFI AVENTIS·Filed 2008·Application pending·0 cites
- 1339US5527795AMercaptoacetylamide derivatives useful as inhibitors of enkephalinase and aceMERRELL PHARMA INC·Filed 1995·Granted Jun 18, 1996·1 cites·13 claims
- 1439US2012202795A1Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)WEINTRAUB PHILIP M·Filed 2012·Application pending·0 cites
- 1538US5698523AAcylated enol derivatives as prodrugs of elastase inhibitorsMERRELL PHARMA INC·Filed 1996·Granted Dec 16, 1997·2 cites·24 claims
- 1637US2004115710A1Method for assaying compounds that decrease the activity of poly (ADP-ribose)-Polymerase (PARP)AVENTIS PHARMA INC·Filed 2003·Application pending·0 cites
- 1735US6172044B1Acylated enol derivative of α-ketoesters and α-ketoamidesAVENTIS PHARMA INC·Filed 1999·Granted Jan 9, 2001·2 cites·13 claims
- 1835US5880119AMercaptoacetylamino 1,3,4,5-tetrahydro-benzo(C)azepin-2-one disulfide derivatives useful as inhibitors of enkephalinase and ACEMERRELL PHARMA INC·Filed 1997·Granted Mar 9, 1999·1 cites·16 claims
- 1935US5629309A2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACEMERRELL PHARMA INC·Filed 1995·Granted May 13, 1997·1 cites·13 claims
- 2031US5972897AAcylated enol derivatives as prodrugs of elastase inhibitorsMERRELL PHARMA INC·Filed 1997·Granted Oct 26, 1999·0 cites·15 claims
- 2130US5750521AMercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACEHOECHST MARION ROUSSEL INC·Filed 1994·Granted May 12, 1998·0 cites·29 claims
- 2230US5604221AIndane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinaseMERRELL PHARMA INC·Filed 1995·Granted Feb 18, 1997·0 cites·22 claims
- 2330US5567814A2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACEMERRELL PHARMA INC·Filed 1995·Granted Oct 22, 1996·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →